Masimo sues US Customs over approval of Apple Watch imports
WASHINGTON (Reuters) -Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple to import Apple Watches with blood-oxygen reading technology during a patent dispute between the companies.
Masimo said in the lawsuit in Washington, D.C., federal court that Customs improperly determined that Apple can import watches with pulse oximetry technology, reversing its own decision from last year without notifying Masimo.
Masimo told the court that it learned of the agency's August 1 decision only after Apple announced it would reintroduce blood-oxygen reading to its watches last week.
Spokespeople for Apple and Customs did not immediately respond to requests for comment. A Masimo spokesperson declined to comment.
Irvine, California-based Masimo has accused Apple of hiring away its employees and stealing its pulse oximetry technology to use in its Apple Watches. Masimo has separately sued Apple for patent infringement and trade secret theft in ongoing federal court cases.
Masimo convinced the U.S. International Trade Commission to block imports of Apple's Series 9 and Ultra 2 smartwatches in 2023 based on a determination that Apple's technology for reading blood oxygen levels infringed Masimo's patents.
Apple has continued to sell Customs-approved redesigned watches without pulse oximetry since the ITC's decision.
Apple said on Aug. 14 that it would reintroduce its smartwatches' blood-oxygen reading capabilities with approval from Customs. Masimo said the agency's decision to approve the watches without input from Masimo or any "meaningful justification" deprived the company of its rights.
"CBP's function is to enforce ITC exclusion orders, not to create loopholes that render them ineffective," Masimo said.
Masimo asked the Washington court to halt the agency's ruling and continue to block Apple from selling watches with the blood-oxygen feature.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
UK's WH Smith cuts profit outlook for North American operations
(Reuters) -British travel retailer WH Smith lowered its full-year profit outlook for its North America division on Thursday after a review uncovered an overstatement of earnings linked to supplier income. The company now expects its headline trading profit at the division to come in at 25 million pounds ($33.62 million), down from previous forecast of about 55 million pounds. ($1 = 0.7435 pounds) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 minutes ago
- Yahoo
James Hardie's Australia shares stare at biggest two-day drop on weak forecast
(Reuters) -James Hardie's Australia-listed shares fell more than 11% on Thursday and were headed for their biggest two-day drop on record after the fibre cement maker forecast 2026 earnings below analyst expectations, citing a weak North America market. The stock has now declined 36% to A$28.34 over the past two days, shedding more than A$9 billion ($5.78 billion) in market value in a selloff that shows broader investor frustration with Australia-listed companies failing to meet targets. The selloff began on Wednesday after the dual-listed company forecast adjusted operating earnings of $1.05 billion-$1.15 billion for fiscal 2026, missing a Visible Alpha consensus estimate of $1.23 billion. The midpoint of the forecast range also barely exceeded the $1.1 billion the company earned in fiscal 2025. Dublin-based James Hardie is grappling with a slowdown in its largest market North America, where weaker-than-expected single-family construction activity during the summer worsened demand for repair and remodelling work. Its North American fibre cement sales fell 12% to $641.8 million in the first quarter, while adjusted net income dropped to $126.9 million from $177.6 million a year earlier. The stock has lost nearly half its value this year, down 42.7% amid a slump in new single-family home sales in the U.S. due to higher borrowing costs and elevated inventory levels. Macquarie analysts flagged James Hardie's stretched balance sheet in a note, questioning the sustainability of its share buyback programme amid $5.1 billion in drawn debt pressuring its finances. Meanwhile, CSL shares tumbled nearly 20% in the two sessions through Wednesday, after the biotech firm ditched its key margin restoration goal for its blood plasma division, joining James Hardie in disappointing Australian investors with earnings-related setbacks. ($1 = 1.5579 Australian dollars)
CNBC
8 minutes ago
- CNBC
CNBC Daily Open: Tech sell-off? Investors could just be taking profit and enjoying the summer
If you have any U.S. technology stocks in your portfolio (and let's face it, who doesn't?), you might want to look away. For the second day in a row, tech stocks dragged markets lower, with the Nasdaq Composite slipping 0.67%. Juggernauts such as Apple, Amazon and Alphabet were more meh-nificent than magnificent, falling more than 1%. Palantir — the standout S&P 500 stock, having more than doubled so far this year — had its sixth consecutive day in the red and lost its place among a ranking of the 20 most valuable U.S. companies. While Palantir's slide was partly triggered by a report from short seller Andrew Left's Citron Research, which called the company "detached from fundamentals and analysis," there was no single trigger for the broader pullback. Investors could have been spooked by OpenAI CEO Sam Altman's caution about an AI bubble forming, although some analysts dispute that assertion. "In our view the tech bull cycle will be well intact at least for another 2-3 years," said Wall Street tech bull Dan Ives. Or it could be something benign, like traders locking in profits. "Tech stocks," said Carol Schleif, chief market strategist at BMO Private Wealth, "have had an incredibly strong run – with some up over 80% since the early April lows." Summer, after all, is far from over. Some investors might have just wanted to cash out for another round of margaritas. Fed officials divided over inflation and employment worries. Central bank governors generally agreed there were risks on both sides. But a couple — breaking from the majority — saw the labor market woes as more pressing, according to minutes of the Fed's July meeting. No new solar or wind power projects, Trump says. Renewable energy projects will no longer receive approval, Trump posted Wednesday on Truth Social. His comment comes after the administration already tightened federal permitting last month. Meta Platforms freezes hiring artificial intelligence talent. The tech giant had in recent months been splashing out eye-watering amounts of money — up to $100 million on signing bonuses — to poach AI employees at other firms. But it appears that cash pool's left to dry for now. Fourth day of losses for the S&P 500. Technology stocks declined on Wednesday, with Palantir having its sixth straight losing day. Asia-Pacific markets were mostly lower Thursday — but Australia's S&P/ASX 200 rose to break the 9,000 level for the first time. [PRO] The Fed is expected to cut just as markets trade at highs. This is what tends to happen when both factors coincide, according to Goldman Sachs research. Red carpet for Putin, trade relief for China, penalties on India: Inside Trump's peculiar policy playbook U.S. President Donald Trump is pursuing an unusual strategy — courting Russian President Vladimir Putin, holding fire on Beijing, all the while turning the screws on India. Despite India being one of the earliest nations to engage in negotiations with the Trump administration, there is still no sign of it sealing a deal with America. New Delhi is now also staring at a secondary tariff of 25% or a "penalty" for its purchases of Russian oil that is set to come into effect later this month.
